Physician profile
Benjamin E Massey
NPI 1346892627
$1,712.54
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $234 · 2021: $412 · 2022: $455 · 2023: $451 · 2024: $26.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $246.85 | 2022-2023 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $239.14 | 2022-2023 | Infuse |
| Sun Pharmaceutical Industries INC. | $235.17 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $226.15 | 2019-2021 | |
| Oyster Point Pharma, INC. | $139.07 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $129.30 | 2023-2024 | Catalys System, Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $124.97 | 2020-2023 | |
| Kala Pharmaceuticals, INC. | $124.46 | 2021 | |
| Alcon Vision LLC | $106.42 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $81.25 | 2023 | Acthar |
| Allergan, INC. | $23.42 | 2020 | |
| Genentech USA, INC. | $23.13 | 2019 | |
| Aerie Pharmaceuticals, INC. | $13.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Massey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.